kind body care glp-1 patches Don't want a full shot? Just need a little boost to curb the cravings? Try the patch GLP-1 Companion System

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

WHO GLP-1 Treatments: The World Health Organization has issued new guidelines endorsing GLP-1 agonists as essential treatments for obesity, highlighting the urgent need for action against the rising global obesity epidemic affecting over one billion people and posing serious health risks.

Learn about Farxiga side effects, from common ones like increased urination to more serious

Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Professional tirzepatide therapy includes complete injection kit with syringes and free telehealth support